OpenURL Connection Search

Select item for more details and to access through your institution.

Preferential B cell differentiation by combined immune checkpoint blockade for renal cell carcinoma is associated with clinical response and autoimmune reactions.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3543, doi. 10.1007/s00262-023-03505-4
By:
- Uehara, Koki;
- Tanoue, Kenro;
- Yamaguchi, Kyoko;
- Ohmura, Hirofumi;
- Ito, Mamoru;
- Matsushita, Yuzo;
- Tsuchihashi, Kenji;
- Tamura, Shingo;
- Shimokawa, Hozumi;
- Isobe, Taichi;
- Shibata, Yoshihiro;
- Ariyama, Hiroshi;
- Tanaka, Risa;
- Kusaba, Hitoshi;
- Yamamoto, Hidetaka;
- Oda, Yoshinao;
- Akashi, Koichi;
- Baba, Eishi
Publication type:
Article
Predictive impact of C-reactive protein to albumin ratio for recurrent or metastatic head and neck squamous cell carcinoma receiving nivolumab.
Published in:
Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-82448-1
By:
- Tanoue, Kenro;
- Tamura, Shingo;
- Kusaba, Hitoshi;
- Shinohara, Yudai;
- Ito, Mamoru;
- Tsuchihashi, Kenji;
- Shirakawa, Tsuyoshi;
- Otsuka, Taiga;
- Ohmura, Hirofumi;
- Isobe, Taichi;
- Ariyama, Hiroshi;
- Koreishi, Sakuya;
- Matsushita, Yuzo;
- Shimokawa, Hozumi;
- Tanaka, Risa;
- Mitsugi, Kenji;
- Akashi, Koichi;
- Baba, Eishi
Publication type:
Article
Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer.
Published in:
Gastric Cancer, 2018, v. 21, n. 3, p. 464, doi. 10.1007/s10120-017-0759-9
By:
- Makiyama, Akitaka;
- Arimizu, Kohei;
- Hirano, Gen;
- Makiyama, Chinatsu;
- Matsushita, Yuzo;
- Shirakawa, Tsuyoshi;
- Ohmura, Hirofumi;
- Komoda, Masato;
- Uchino, Keita;
- Inadomi, Kyoko;
- Arita, Shuji;
- Ariyama, Hiroshi;
- Kusaba, Hitoshi;
- Shinohara, Yudai;
- Kuwayama, Miyuki;
- Kajitani, Tatsuhiro;
- Oda, Hisanobu;
- Esaki, Taito;
- Akashi, Koichi;
- Baba, Eishi
Publication type:
Article

Found: 3

Preferential B cell differentiation by combined immune checkpoint blockade for renal cell carcinoma is associated with clinical response and autoimmune reactions.

Predictive impact of C-reactive protein to albumin ratio for recurrent or metastatic head and neck squamous cell carcinoma receiving nivolumab.

Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer.